|
|
proteasomal ubiquitin independent protein catabolic process
|
GO:0010499 |
3 |
0.938
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
33 |
0.800
|
Mouse |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.712
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.697
|
Human |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.631
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.619
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.596
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.589
|
Human |
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.588
|
Human |
|
|
spindle elongation
|
GO:0051231 |
4 |
0.557
|
|
|
|
isg15 protein conjugation
|
GO:0032020 |
5 |
0.454
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.429
|
Human Mouse |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.409
|
Human |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.406
|
Human |
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.373
|
Human |
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.363
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.342
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.306
|
Human |
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.298
|
Human Mouse |
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.291
|
Human |
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.267
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.264
|
Human |
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.228
|
Human Mouse |
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.227
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.207
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.188
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.188
|
Human |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.176
|
Human |
|
|
nervous system development
|
GO:0007399 |
293 |
0.174
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.167
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.162
|
Human Mouse |
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.160
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.141
|
Human Mouse |
|
|
ossification
|
GO:0001503 |
121 |
0.139
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.128
|
|
|
|
viral entry into host cell
|
GO:0046718 |
24 |
0.114
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.107
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.094
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.090
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.090
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.088
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.080
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
25 |
0.075
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.074
|
Human |
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.071
|
Human Mouse |
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.068
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.060
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.059
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.058
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
14 |
0.058
|
|
|
|
regulation of antigen processing and presentation of peptide antigen
|
GO:0002583 |
4 |
0.057
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.056
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
25 |
0.055
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.053
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.053
|
|
|
|
negative regulation of type i interferon mediated signaling pathway
|
GO:0060339 |
4 |
0.051
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.050
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.050
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.049
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.049
|
|
|
|
entry into host
|
GO:0044409 |
25 |
0.047
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.047
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.047
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.046
|
|
|
|
t cell proliferation
|
GO:0042098 |
45 |
0.045
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.045
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.044
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.043
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.043
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.041
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.041
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.041
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.040
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.040
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.040
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.037
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.037
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.035
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.035
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.034
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.033
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.033
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.032
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.032
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.031
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.030
|
|
|
|
multi organism localization
|
GO:1902579 |
14 |
0.030
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.029
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.029
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
12 |
0.029
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.027
|
|
|
|
negative regulation of gene silencing by rna
|
GO:0060967 |
3 |
0.026
|
|
|
|
response to muramyl dipeptide
|
GO:0032495 |
4 |
0.026
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.026
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.026
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.025
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.025
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.025
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.024
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.024
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.024
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.024
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.023
|
|
|
|
rna modification
|
GO:0009451 |
27 |
0.023
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.022
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.022
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.022
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.021
|
|
|
|
molting cycle
|
GO:0042303 |
28 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.021
|
|
|
|
entry into host cell
|
GO:0030260 |
25 |
0.021
|
|
|
|
adenosine to inosine editing
|
GO:0006382 |
3 |
0.021
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.020
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.020
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.020
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.019
|
|
|
|
mitotic spindle elongation
|
GO:0000022 |
4 |
0.019
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.018
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.018
|
Human |
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.018
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.018
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.017
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.017
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.017
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
18 |
0.017
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.016
|
|
|
|
proteasome assembly
|
GO:0043248 |
7 |
0.016
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.016
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.016
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.015
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.015
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
36 |
0.015
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.015
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.015
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.014
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.014
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.013
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.013
|
|
|
|
regulation of interleukin 12 production
|
GO:0032655 |
15 |
0.013
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.013
|
Human |
|
|
centrosome organization
|
GO:0051297 |
58 |
0.013
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.013
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.013
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.013
|
|
|
|
response to peptidoglycan
|
GO:0032494 |
3 |
0.013
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.013
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.012
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.012
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.012
|
|
|
|
regulation of viral entry into host cell
|
GO:0046596 |
17 |
0.012
|
|
|
|
regulation of ligase activity
|
GO:0051340 |
29 |
0.012
|
|
|
|
response to interferon alpha
|
GO:0035455 |
11 |
0.012
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.012
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.012
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.012
|
|
|
|
trna aminoacylation
|
GO:0043039 |
12 |
0.012
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.012
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.012
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.012
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.012
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.011
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.011
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.011
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
23 |
0.011
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.011
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.011
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.011
|
|
|
|
basement membrane organization
|
GO:0071711 |
3 |
0.011
|
|
|
|
base conversion or substitution editing
|
GO:0016553 |
4 |
0.011
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.011
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.011
|
|
|
|
system process
|
GO:0003008 |
349 |
0.011
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.011
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.010
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.010
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.010
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.010
|
|
|
|
regulation of protein export from nucleus
|
GO:0046825 |
15 |
0.010
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.010
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.010
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.010
|
|